Skip to main content
. 2020 Jul 3;13:2347–2358. doi: 10.2147/DMSO.S255783

Table 3.

Studies Evaluating the Effects of Carotenoids on Retinal Tissue of Diabetic Animal Models

Author, Year Animal Models Carotenoids Effects on Diabetic Retinopathy
1 McClinton,
201935
STZ-induced diabetic rat Carotenoid-rich
diet
  • Aggravate a- and b-wave amplitude in electroretinography

  • Aggravate a-, OP- and b-wave latency in electroretinography

2 Sharavana,
201736
STZ-induced diabetic rat Lutein
  • Increase GSH levels and SOD activity

  • Decrease carbonyl and MDA levels

  • Decrease expression of VEGF and VEGF receptor

  • Decrease co-receptor and transcription factor of VEGF receptor

  • Decrease hypoxia-inducible factor

  • Prevent RGC loss and maintain INL thickness

3 Yeh,
201637
STZ-induced diabetic rats Astaxanthin
Lutein
  • Decrease 8-OHdG, nitrotyrosine and acrolein levels

  • Enhance hemeoxygenase, peroxiredoxin and thioredoxin activity

  • Decrease NF-kB levels

  • Decrease MCP-1, fractalkine and ICAM-1 levels

  • Prevent RGC loss and maintain TR, IPL, INL, and ORL thickness

  • Restore b-wave amplitude in electroretinography

4 Kowluru,
201438
STZ-induced diabetic rats Lutein, zeaxanthin-rich
diet
  • Decrease ROS and increase total antioxidant capacity

  • Decrease VEGF, NF-kB, IL-1β levels

  • Reduce mitochondrial DNA damages

  • Reduce capillary cell apoptosis

  • Restore a- and b-wave amplitude in electroretinography

5 Yu,
201339
Transgenic diabetic mice Zeaxanthin, Lutein-rich wolfberry diet
  • Enhance expression of TFAM and PCG-1

  • Decrease expression of hypoxia-inducible factor, VEGF and HSP60

  • Enhance expression of AMPK

6 Tang,
201140
Transgenic diabetic mice Zeaxanthin, Lutein, Cryptoxanthin-rich wolfberry diet
  • Enhance expression of thioredoxin, SOD and FOXO3α

  • Decrease BiP, PERK, ATF6, caspase-3 and caspase-12 levels

  • Enhance activation of AMPK

  • Suppress capillary-like structure formation

  • Decrease disorganized nuclear distribution in the ONL

  • Prevent RGC loss and restore RPL and INL thinking

7 Sasaki,
201041
STZ-induced diabetic mice Lutein-rich diet
  • Decrease ROS levels

  • Increase BDNF and synaptophysin levels

  • Inhibit activation of ERK signaling pathway

  • Reduce cell apoptosis and caspase-3 levels

  • Prevent RGC loss and maintain INL and IPL thickness

  • Restore OP amplitude in electroretinography

8 Kowluru,
200943
Alloxan-induced diabetic rats β-carotene-containing
supplement
  • Decrease NF-kB levels

  • Decrease expression of iNOS

  • Decrease lipid peroxides, nitrotyrosine and NO levels

9 Kowluru,
200942
Alloxan-induced diabetic rats β-carotene-containing
supplement
  • Decrease lipid peroxides

  • Inhibit activation of caspase-3

10 Arnal,
200944
STZ-induced diabetic rats Lutein
  • Decrease MDA and nitrotyrosine levels

  • Enhance glutathione peroxidase activity and GSH levels

  • Reduce apoptosis

  • Prevent RGC loss and maintain INL ONL, and TR thickness

  • Restore b-wave amplitude and latency in electroretinography

11 Kowluru,
200845
STZ-induced diabetic rats Carotenoid-rich
diet
  • Decrease Lipid peroxide, nitrotyrosine, and 8-OHdG level

  • No beneficial effect on GSH levels

  • Decrease expression of iNOS

  • Increase expression of SOD and mitochondrial complex III

  • Decrease VEGF and ICAM-1 levels

12 Kowluru,
200845
STZ-induced diabetic rats Carotenoid-rich
diet
  • Decrease nitrotyrosine and 8-OHdG level

  • Increase expression of SOD and catalase

  • Increase expression of iNOS and mitochondrial complex III

  • Decrease acellular capillaries

13 Muriach,
200647
Alloxan-induced diabetic mice Lutein
  • Decrease MDA and NF-kB levels

  • Increase GSH levels and glutathione peroxidase activity

  • Restore b-wave amplitude in electroretinography

14 Dene,
200548
STZ-induced diabetic rats β-carotene
  • No beneficial effect on gamma-glutamyltransferase activity

  • Increase glutathione reductase activity

15 Kowluru,
200146
STZ-induced diabetic rats β-carotene-rich diet
  • Decrease glutamate levels

  • Decrease lipid peroxides and NO levels

Abbreviations: GSH, reduced glutathione; MDA, malondialdehyde; VEGF, vascular endothelial growth factor; RGC, retinal ganglion cell; TR, total retina; IPL, inner plexiform layer; INL, inner nuclear layer; ORL, outer retinal layers; RPL, retina photoreceptor layer; OP, oscillatory potential; 8-OHdG, deoxyguanosine; ICAM-1, intercellular adhesion molecule-1; MCP-1, monocyte chemoattractant protein-1; NF-kB, nuclear factor kB; ROS, reactive oxygen species; IL-1β, interleukin 1 beta; HSP60, heat shock protein 60; AMPKα, AMP-activated protein kinase alpha; BiP, binding immunoglobulin protein; PERK, protein kinase RNA-like ER kinase; ATF6, activating transcription factor 6; SOD, superoxide dismutase; FOXO3α, forkhead O transcription factor 3 alpha; TNF-α, tumor necrosis factor alpha; BDNF, brain-derived neurotrophic factor; NO, nitric oxide; iNOS, inducible nitric oxide synthase; ERK, extracellular signal-regulated kinases.